A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients

Denosumab has been suggested as a first-line therapy for osteoporotic patients. However, a standardized protocol for the prevention of denosumab induced medication-related osteonecrosis of the jaw (MRONJ) has not yet been established. The purpose of this study was to report denosumab induced MRONJ c...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Seoyeon, Kim, Jaeyeon, Park, Jin Hoo, Kim, Ki-Yeol, Kim, Hyung Jun, Park, Wonse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126865/
https://www.ncbi.nlm.nih.gov/pubmed/35606457
http://dx.doi.org/10.1038/s41598-022-11615-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126865/
https://www.ncbi.nlm.nih.gov/pubmed/35606457
http://dx.doi.org/10.1038/s41598-022-11615-9

Ejemplares similares